000 02783nam a2200385 i 4500
999 _c393045
_d393045
_x1
001 393045
003 ES-MaUEC
005 20240314174309.0
006 a|||| o|||| 00| 0
007 cr nn 008mamaa
008 130109s2013 xxua o |||| 0|eng d
020 _a9781627032308
024 7 _a10.1007/978-1-62703-230-8
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aQP550
_b2013 EB
245 0 0 _aCalcium-Binding Proteins and RAGE :
_bFrom Structural Basics to Clinical Applications
_cedited by Claus W. Heizmann
250 _a1st edition 2013
264 1 _aTotowa, NJ
_bHumana Press
_c2013
300 _a1 recurso en línea (XIV, 423 páginas)
_b85 ilustraciones, 56 ilustraciones a color
336 _atexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
490 0 _aMethods in Molecular Biology
_x1940-6029
_v963
520 _aA major direction in medical research leading to clinical applications  targets the regulation of intracellular calcium and the various human diseases associated with an altered homeostasis of this global second messenger. These diseases include, for example: cardiomyopathy, inflammation, brain disorders, diabetes and cancer. In Calcium Binding Proteins and RAGE: from Structural Basics to Clinical Applications, expert researchers in the field detail many of the methods which are now commonly used to study calcium binding proteins. These methods and techniques, such as calcium-measurements, screening methods, clinical chemistry, and therapy, are generally applicable to many other areas of basic and medical research as well as to diagnostics. Written in the highly successful Methods in Molecular Biology™ series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and key tips on troubleshooting and avoiding known pitfalls.   Authoritative and practical, Calcium Binding Proteins and RAGE: from Structural Basics to Clinical Applications underlines the diagnostic and clinical importance of this family of proteins in human diseases and as drug targets.
988 _aSpringer_Protocols_2013
650 7 _2embne
_9668476
_aQuímica bioorgánica
776 0 8 _iPrinted edition:
_z9781627032292
776 0 8 _iPrinted edition:
_z9781627032315
776 0 8 _iPrinted edition:
_z9781493959761
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-1-62703-230-8
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
998 _b01/2024
_dz
_eb
_zSI